Skip to content
Homepage
Clinic directory

Clinics in Austin, Texas

Every listing is checked against federal records, reviewed for evidence, and confirmed still operating. No pay-to-play. No guesswork.

  • No results found.
  • No results found.

Austin, TX

Stem Cell Therapy clinics in Austin

Austin supports a regenerative medicine market shaped by both private clinics and regional academic medicine. Local referral networks run through Dell Medical School at UT Austin and Ascension Seton, and stem cell practice in the area spans downtown, Westlake, and North Austin. Patient demand splits across three buckets: orthopedic injections for active adults and aging athletes, neurological and autoimmune protocols marketed to longevity-focused patients, and IV-based allogeneic products offered by private wellness clinics. The FDA classifies most stem cell injections for orthopedic, neurological, or longevity use as investigational biologics under 21 CFR Part 1271, meaning they require either a Biologics License or an active Investigational New Drug authorization. Autologous bone marrow and adipose products may qualify as Section 361 when minimally manipulated and used for homologous function. House Bill 810 (2017) permits licensed Texas physicians to administer investigational adult stem cell treatments for patients with severe chronic diseases or terminal illnesses under institutional review board oversight, without an FDA Investigational New Drug authorization. Texas Medical Board licensure is required, and advertising is regulated under the Texas Occupations Code. The 22 Austin clinics listed below have been reviewed against our vetting criteria, including federal NPI lookup, OIG exclusion screening, and Texas Medical Board licensure checks.

20 Clinics, showing page 2 of 2

MD on staff

MATTR BIOwellness Club

Austin, TX

MATTR BIOwellness Club, an oxygen and energy-therapies clinic in Austin, offers hyperbaric oxygen therapy, cryotherapy, and whole-body cryotherapy alongside IV nutrient and peptide protocols. The cli…

  • Vitamin IV Therapy
  • IV Therapy
  • Hyperbaric Oxygen Therapy (HBOT)
  • Cryotherapy
  • Red Light Therapy

PÜR LIFE Medical

Austin, TX

PÜR LIFE Medical in Austin specializes in hormone replacement therapy, testosterone replacement therapy, and peptide therapy for patients pursuing hormone optimization and longevity support. The clin…

  • PRP Therapy
  • Shockwave Therapy
  • IV Therapy
  • Acne Treatment
  • Arthritis Treatment
MD on staff

Humanaut Health

Austin, TX

Humanaut Health Austin, a longevity clinic in Austin, offers peptide therapy, stem-cell therapy, and regenerative-medicine protocols tailored to individual patient goals. The practice combines hormon…

  • IV Therapy
  • Oxygen Therapy
  • Peptide Therapy
  • Hormone Replacement Therapy (HRT)
  • Stem Cell Therapy

Austin Foot & Ankle Center - South

Austin, TX

Austin Foot & Ankle Center – South, a regenerative-medicine clinic in Austin, specializes in stem-cell therapy for foot and ankle conditions alongside conventional podiatric care. The practice offers…

  • Laser Therapy (LLLT)
  • Arthritis Treatment
  • Stem Cell Therapy

The Center For Healing And Regenerative Medicine

Austin, TX

The Center For Healing And Regenerative Medicine, a regenerative-medicine clinic in Austin, specializes in stem-cell therapy for patients with chronic pain, musculoskeletal injury, and degenerative c…

  • Arthritis Treatment
  • Migraine Treatment
  • TMJ Treatment
  • Stem Cell Therapy

Regulatory context

A note on Texas's stem cell therapy rules.

Texas cellular therapy is governed by 21 CFR Part 1271. Section 361 covers minimally manipulated HCT/Ps used for homologous use without premarket approval. Section 351 covers products that are more than minimally manipulated, used non-homologously, or combined with another article, and these require an IND for clinical use or a BLA for marketing. Most stem cell, stromal vascular fraction, and exosome therapies marketed in Texas for orthopedic, neurologic, and longevity indications are Section 351 biologics that lack FDA approval. Texas enacted a state-level investigational adult stem cell framework in 2017 that does not override federal law.

  • Texas HB 810 (2017), Texas Health and Safety Code Chapter 1003
    Authorizes administration of investigational adult stem cell treatments to eligible patients with severe chronic or terminal illness when conducted by Texas-licensed physicians at facilities meeting defined institutional review board oversight criteria.
  • Texas Medical Practice Act, Texas Occupations Code Title 3, Subtitle B
    Establishes physician licensure and discipline through the Texas Medical Board.
  • Texas Pharmacy Act, Texas Occupations Code Chapter 551 et seq
    Regulates compounding pharmacies aligned with federal 503A and 503B standards.

The FDA has issued warning letters to Texas clinics offering stem cell and exosome therapies. The Texas Medical Board has disciplined physicians for unprofessional conduct including misleading regenerative medicine advertising. The Texas Attorney General has used the Texas Deceptive Trade Practices Act to pursue providers making unsupported clinical claims. HB 810 expressly does not preempt federal law, so even Texas providers operating under HB 810 must comply with 21 CFR Part 1271 and remain subject to FDA enforcement if products fall outside Section 361.

Stem Cell Therapy in Austin, answered.

Most stem cell therapies at private Austin clinics are not FDA-approved. The FDA has approved certain hematopoietic stem cell products for blood and immune disorders, but stem cell injections for orthopedic, neurological, or longevity use are generally investigational. They require a Biologics License or an active Investigational New Drug authorization, or they must qualify as Section 361 minimally manipulated and homologous-use products under 21 CFR Part 1271. House Bill 810 (2017) permits licensed Texas physicians to administer investigational adult stem cell treatments for patients with severe chronic diseases or terminal illnesses under institutional review board oversight, without an FDA Investigational New Drug authorization.

In the Austin metro, single-joint autologous bone marrow or adipose injections typically run $4,000 to $12,000 per session. Systemic IV protocols using allogeneic umbilical cord or Wharton's jelly products range $8,000 to $20,000, and full multi-session protocols can reach $15,000 to $40,000. Exosome add-ons range $3,500 to $7,500. Insurance rarely covers these treatments because the FDA classifies most protocols as investigational.

Autologous stem cells come from your own body, usually harvested from bone marrow aspirate or adipose tissue and reinjected the same day. When minimally manipulated and used for homologous function, they often fall under FDA Section 361, which does not require pre-market approval. Allogeneic stem cells come from a donor source, most commonly umbilical cord blood or Wharton's jelly, and are generally classified as Section 351 biologics that require an active Investigational New Drug authorization. Austin clinic offerings span both categories, so ask which classification applies before treatment.

Yes. Research programs at Dell Medical School at UT Austin and Ascension Seton periodically run FDA-authorized stem cell trials across orthopedics, neurology, cardiology, and oncology. Search clinicaltrials.gov and filter by Austin or the broader metro to see active recruiting studies. Trial participation is typically low-cost or free compared to commercial protocols and includes structured follow-up with imaging and lab monitoring.

Verify physician licensure through the Texas Medical Board and confirm the clinic's NPI number through the NPPES registry. Check the FDA warning letter database for the clinic name and the HHS Office of Inspector General exclusion list. Ask whether the treatment is Section 361 or Section 351, whether the clinic operates under an Investigational New Drug authorization for allogeneic or expanded products, and whether adverse events are tracked. Ask specifically about compliance with HB 810.

Filters

Rating

Treatments

Advanced Therapies 1
Chronic, Immune & Hormonal
Digestive & Respiratory
IV & Infusion
Pain & Musculoskeletal
Skin & Aesthetics
Mental Health & Neurology